|
Volumn 51, Issue 6, 2010, Pages 753-
|
Letter in response to the Infectious Diseases Society of America's 10 × '20 initiative
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ACINETOBACTER BAUMANNII;
BACTERIAL INFECTION;
DRUG COST;
DRUG MARKETING;
ENTEROCOCCUS FAECIUM;
HUMAN;
INFECTIOUS DISEASE MEDICINE;
KLEBSIELLA PNEUMONIAE;
LETTER;
MEDICAL SOCIETY;
PHARMACIST;
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
STAPHYLOCOCCUS AUREUS;
ANTI-BACTERIAL AGENTS;
BACTERIAL INFECTIONS;
DRUG DISCOVERY;
DRUG RESISTANCE, BACTERIAL;
DRUG UTILIZATION;
HEALTH POLICY;
HUMANS;
|
EID: 77955931426
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/655957 Document Type: Letter |
Times cited : (2)
|
References (4)
|